Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers

Sung Hoon Kang, Hanna Cho, Jiho Shin, Hang Rai Kim, Young Noh, Eun Joo Kim, Chul Hyoung Lyoo, Hyemin Jang, Hee Jin Kim, Seong Beom Koh, Duk L. Na, Mee Kyung Suh, Sang Won Seo

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Primary progressive aphasia (PPA) is associated with amyloid-β (Aβ) pathology. However, clinical feature of PPA based on Aβ positivity remains unclear. Objective: We aimed to assess the prevalence of Aβ positivity in patients with PPA and compare the clinical characteristics of patients with Aβ-positive (A+) and Aβ-negative (A-) PPA. Further, we applied Aβ and tau classification system (AT system) in patients with PPA for whom additional information of in vivo tau biomarker was available. Methods: We recruited 110 patients with PPA (41 semantic [svPPA], 27 non-fluent [nfvPPA], 32 logopenic [lvPPA], and 10 unclassified [ucPPA]) who underwent Aβ-PET imaging at multi centers the extent of language impairment and cortical atrophy were compared between the A+ and A-PPA subgroups using general linear models. Results: The prevalence of Aβ positivity was highest in patients with lvPPA (81.3%), followed by ucPPA (60.0%), nfvPPA (18.5%), and svPPA (9.8%) the A+ PPA subgroup manifested cortical atrophy mainly in the left superior temporal/inferior parietal regions and had lower repetition scores compared to the A-PPA subgroup. Further, we observed that more than 90% (13/14) of the patients with A+ PPA had tau deposition. Conclusion: Our findings will help clinicians understand the patterns of language impairment and cortical atrophy in patients with PPA based on Aβ deposition. Considering that most of the A+ PPA patents are tau positive, understanding the influence of Alzheimer's disease biomarkers on PPA might provide an opportunity for these patients to participate in clinical trials aimed for treating atypical Alzheimer's disease.

Original languageEnglish
Pages (from-to)633-645
Number of pages13
JournalJournal of Alzheimer's Disease
Volume84
Issue number2
DOIs
Publication statusPublished - 2021

Bibliographical note

Funding Information:
This study was supported by the Fourth Stage of Brain Korea 21 Project in Division of Intelligent Precision Healthcare, a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare and Ministry of science and ICT, Republic of Korea (grant number : HU20C0111), and a fund (2021-ER1006-00) by Research of Korea Disease Control and Prevention Agency.

Publisher Copyright:
© 2021-IOS Press. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers'. Together they form a unique fingerprint.

Cite this